A detailed history of Zimmer Partners, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Zimmer Partners, LP holds 38,000 shares of CYTK stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
38,000
Previous 77,200 50.78%
Holding current value
$1.65 Million
Previous $4.08 Million 56.16%
% of portfolio
0.03%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$46.36 - $58.62 $1.82 Million - $2.3 Million
-39,200 Reduced 50.78%
38,000 $1.79 Million
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $768,300 - $902,400
-15,000 Reduced 16.27%
77,200 $4.08 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $2.57 Million - $4.02 Million
53,600 Added 138.86%
92,200 $5 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $2.46 Million - $4.17 Million
38,600 New
38,600 $2.71 Million
Q2 2023

Aug 14, 2023

BUY
$32.62 - $40.75 $1.63 Million - $2.04 Million
50,000 New
50,000 $1.63 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.08B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.